Approved Hospital Formulary
QR Code Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:

aprepitant

aprepitant
Brand names: Emend
Form Strength
CAPSULE, ORAL 40 mg, 80 mg, 125 mg


Additional Information:

Formulary Restriction: Aprepitant is restricted to use for prevention and treatment of nausea and vomiting in moderate and highly emetogenic chemotherapy therapy or one-time pre-operative dose for bariatric surgery patients only.

NON-formulary for all other post-operative nausea and vomiting indications. See P & T Committee for more information

 


Last updated: Jan. 11, 2022







This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.